Trial Of Onco-panel for Geneprofiling

Trial Of Onco-panel for Geneprofiling - NCC Onco-panel Advanced Medical Care

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000032166

Enrollment

350

Registered

2018-04-09

Start date

2018-04-09

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant solid tumors or Cancer of unknown primary

Interventions

Multiplex genomic testing

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Age over 16 years 2) ECOG PS 0 to 1 3) Pathologically diagnosed as malignant solid tumor 4) Inoperable or recurrent tumor as follows 1.Cancer of unknown primary 2.Solid tumor progressed after standard chemotherapy 5) have samples for testing 4) Written informed consent

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Detection rate of actionable genomic change.	—

Countries

Japan

Contacts

Public ContactNatsuko Okita

National Cancer Center Hospital Crinical Trial Support Office

NCCH1616_office@ml.res.ncc.go.jp03-3542-2511

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026